Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000898432-04-000114
Filing Date
2004-02-04
Accepted
2004-02-04 14:12:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 bvf-atherogenics_13ga.htm SC 13G/A 92136
  Complete submission text file 0000898432-04-000114.txt   94095
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address
Business Address 8995 WESTSIDE PARKWAY ALPHARETTA GA 30004 6783362500
ATHEROGENICS INC (Subject) CIK: 0001107601 (see all company filings)

EIN.: 582108232 | State of Incorp.: GA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60563 | Film No.: 04566130
SIC: 2834 Pharmaceutical Preparations